Lars M.
- Country
- Denmark
- Department
- Department of Neurology
Research Overview
- Evaluation of Subcutaneous Versus Intravenous Human Normal Immunoglobulin in Treatment-Naïve Patients with Chronic Inflammatory Demyelinating Polyneuropathy
- Pharmacokinetic Comparability Study of TAK-881 and Human Normal Immunoglobulin in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients
- A phase 2, multicenter, randomized, placebo-controlled, double-blind study to investigate the safety, pharmacodynamics, and preliminary efficacy of S-606001 as an add-on to enzyme replacement therapy in patients with late-onset Pompe disease.
Data & Insights
Has run more than one trial at 2 of 41 partner sites.
Specializations
Neurological Disorders
The investigator specializes in the study and treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), focusing on innovative therapeutic approaches for patients with this rare neurological condition.
- Autoimmune Neuropathies
- Immunoglobulin Therapy
- Peripheral Nerve Disorders
Research interests extend to exploring subcutaneous and intravenous administration routes for immunoglobulin treatments in neurological conditions.
Immunotherapy
Dedicated to advancing immunoglobulin treatment methodologies, particularly in comparing subcutaneous versus intravenous administration routes for optimal patient outcomes.
- Novel Drug Delivery Systems
- Treatment Optimization
- Long-term Patient Care
Special focus on developing treatment protocols for newly diagnosed patients requiring immunological interventions.
Clinical Therapeutics
The investigator's work encompasses innovative treatment approaches for neuromuscular disorders, with particular attention to establishing effective therapeutic protocols.
- Treatment Response Assessment
- Patient Monitoring Protocols
- Therapeutic Innovation
Expertise in evaluating treatment efficacy and implementing extended therapeutic interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.